Evidence map›Paper›PMID 37595278›Full record

ArticleBlood2023

Genome-wide transcription factor-binding maps reveal cell-specific changes in the regulatory architecture of human HSPCs.

Shruthi Subramanian, Julie A I Thoms, Yizhou Huang, Paola Cornejo-Páramo, Forrest C Koch, Sebastien Jacquelin, Sylvie Shen, Emma Song, Swapna Joshi, Chris Brownlee and 19 more

Open access · greenAbstract read
In one paragraph

Article in Blood, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Mechanisms of enhancer-driven oncogene activation.International journal of cancer · 2026
    Review
  12. Article
  13. Article
  14. Mechanisms of Globin Gene Regulation in Mammals.Annual review of genetics · 2025
    Review
  15. Article
  16. Flaxseed (Basic and clinical neuroscience · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 14 institutions in 4 countries.

Shruthi SubramanianSchool of Clinical Medicine, University of New South Wales, Sydney, Australia.ORCID 0000-0003-3426-0356
Julie A I ThomsSchool of Biomedical Sciences, University of New South Wales, Sydney, Australia.ORCID 0000-0002-4876-7230
Yizhou HuangCentre for Health Technologies and the School of Biomedical Engineering, University of Technology Sydney, Sydney, Australia.ORCID 0000-0002-7003-3110
Paola Cornejo-PáramoVictor Chang Cardiac Research Institute, Sydney, Australia.ORCID 0000-0002-5057-776X
Forrest C KochSchool of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Sydney, Australia.ORCID 0000-0002-1890-795X
Sebastien JacquelinMacrophage Biology Laboratory, Mater Research, Brisbane, Australia.ORCID 0000-0001-5087-3641
Sylvie ShenBone Marrow Transplant Laboratory, NSW Health Pathology, Prince of Wales Hospital, Randwick, NSW, Australia.
Emma SongBone Marrow Transplant Laboratory, NSW Health Pathology, Prince of Wales Hospital, Randwick, NSW, Australia.
Swapna JoshiSchool of Clinical Medicine, University of New South Wales, Sydney, Australia.
Chris BrownleeMark Wainwright Analytical Centre, University of New South Wales, Sydney, Australia.
Petter S WollDepartment of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Huddinge, Sweden.ORCID 0000-0002-2340-2526
Diego Chacon-FajardoCentre for Health Technologies and the School of Biomedical Engineering, University of Technology Sydney, Sydney, Australia.ORCID 0000-0003-3729-1385
Dominik BeckCentre for Health Technologies and the School of Biomedical Engineering, University of Technology Sydney, Sydney, Australia.
David J CurtisAustralian Centre for Blood Diseases, Monash University, Melbourne, VIC, Australia.ORCID 0000-0001-9497-0996
Kenneth YehsonBlood Transplant and Cell Therapies Laboratory, NSW Health Pathology, Westmead, NSW, Australia.
Vicki AntonenasBlood Transplant and Cell Therapies Laboratory, NSW Health Pathology, Westmead, NSW, Australia.
Tracey O'BrienSydney Children's Hospital, Sydney, Australia.ORCID 0000-0002-5759-6162
Annette TrickettBone Marrow Transplant Laboratory, NSW Health Pathology, Prince of Wales Hospital, Randwick, NSW, Australia.
Jason A PowellCentre for Cancer Biology, SA Pathology, University of South Australia, Adelaide, Australia.
Ian D LewisCentre for Cancer Biology, SA Pathology, University of South Australia, Adelaide, Australia.
Stuart M PitsonCentre for Cancer Biology, SA Pathology, University of South Australia, Adelaide, Australia.ORCID 0000-0002-9527-2740
Maher K GandhiBlood Cancer Research Group, Mater Research, The University of Queensland, Brisbane, QLD, Australia.ORCID 0000-0003-1000-5393
Steven W LaneCancer Program, QIMR Berghofer Medical Research, Brisbane, Australia.ORCID 0000-0002-8050-6209
Fatemeh VafaeeSchool of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Sydney, Australia.ORCID 0000-0002-7521-2417
Emily S WongVictor Chang Cardiac Research Institute, Sydney, Australia.ORCID 0000-0003-0315-2942
Berthold GöttgensWellcome-MRC Cambridge Stem Cell Institute, Cambridge, United Kingdom.ORCID 0000-0001-6302-5705
Hamid Alinejad-RoknyBioMedical Machine Learning Lab, Graduate School of Biomedical Engineering, University of New South Wales, Sydney, Australia.
Jason W H WongSchool of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.ORCID 0000-0003-2953-7728
John E PimandaSchool of Clinical Medicine, University of New South Wales, Sydney, Australia.ORCID 0000-0002-0509-8962
UNSW Sydney · AUPrince of Wales Hospital · AUSouth Australia Pathology · AUUniversity of Technology Sydney · AUNew South Wales Department of Health · AUVictor Chang Cardiac Research Institute · AUKarolinska Institutet · SEMater Research · AUMonash University · AUQIMR Berghofer Medical Research Institute · AUSydney Children's Hospital · AUThe University of Queensland · AUUniversity of Hong Kong · HKWellcome/MRC Cambridge Stem Cell Institute · GB

Funding

Medical Research Council MC_PC_17230Wellcome Trust 206328Wellcome Trust 206328/Z/17/Z
6 · The paper itself

Abstract

Hematopoietic stem and progenitor cells (HSPCs) rely on a complex interplay among transcription factors (TFs) to regulate differentiation into mature blood cells. A heptad of TFs (FLI1, ERG, GATA2, RUNX1, TAL1, LYL1, LMO2) bind regulatory elements in bulk CD34+ HSPCs. However, whether specific heptad-TF combinations have distinct roles in regulating hematopoietic differentiation remains unknown. We mapped genome-wide chromatin contacts (HiC, H3K27ac, HiChIP), chromatin modifications (H3K4me3, H3K27ac, H3K27me3) and 10 TF binding profiles (heptad, PU.1, CTCF, STAG2) in HSPC subsets (stem/multipotent progenitors plus common myeloid, granulocyte macrophage, and megakaryocyte erythrocyte progenitors) and found TF occupancy and enhancer-promoter interactions varied significantly across cell types and were associated with cell-type-specific gene expression. Distinct regulatory elements were enriched with specific heptad-TF combinations, including stem-cell-specific elements with ERG, and myeloid- and erythroid-specific elements with combinations of FLI1, RUNX1, GATA2, TAL1, LYL1, and LMO2. Furthermore, heptad-occupied regions in HSPCs were subsequently bound by lineage-defining TFs, including PU.1 and GATA1, suggesting that heptad factors may prime regulatory elements for use in mature cell types. We also found that enhancers with cell-type-specific heptad occupancy shared a common grammar with respect to TF binding motifs, suggesting that combinatorial binding of TF complexes was at least partially regulated by features encoded in DNA sequence motifs. Taken together, this study comprehensively characterizes the gene regulatory landscape in rare subpopulations of human HSPCs. The accompanying data sets should serve as a valuable resource for understanding adult hematopoiesis and a framework for analyzing aberrant regulatory networks in leukemic cells.

Indexed as

Core Binding Factor Alpha 2 SubunitHematopoietic Stem CellsChromatinGene Expression RegulationHematopoiesisHumansChromatinCore Binding Factor Alpha 2 Subunit

Identifiers

PMID37595278
PMCPMC10651876
OpenAlexW4385972047

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.